ELDN
Eledon Pharmaceuticals Inc
2.70$
-1.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -100.0% | – | -100.0% | – | – | – | – | – | – | |
| – | +0.0% | +1.1% | +2.1% | -18.6% | +11.4% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -10.9% | +4.9% | +36.4% | +63.5% | +8.5% | -24.5% | +49.8% | -26.2% | +16.8% | -1.7% | +6.0% | – | |
| – | +0.1% | +5.7% | +27.1% | -9.2% | +69.6% | -34.5% | +0.5% | -8.0% | -2.6% | -0.2% | +16.4% | – | |
| – | -8.5% | +5.2% | +34.6% | +41.4% | +20.4% | -27.3% | +37.7% | -22.9% | +12.7% | -1.4% | +8.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -157.4% | – | – | – | – | – | – | – | |
| – | -62.4% | +3.1% | +0.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -158.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -157.2% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.